vs

Side-by-side financial comparison of INTRUSION INC (INTZ) and INVO Fertility, Inc. (IVF). Click either name above to swap in a different company.

INVO Fertility, Inc. is the larger business by last-quarter revenue ($1.8M vs $1.5M, roughly 1.2× INTRUSION INC). INVO Fertility, Inc. runs the higher net margin — -150.5% vs -190.7%, a 40.2% gap on every dollar of revenue. On growth, INVO Fertility, Inc. posted the faster year-over-year revenue change (22.6% vs -11.6%). INTRUSION INC produced more free cash flow last quarter ($-549.0K vs $-1.8M). Over the past eight quarters, INTRUSION INC's revenue compounded faster (14.4% CAGR vs 12.8%).

Intrusion Inc. is a cybersecurity company based in Plano, Texas. It provides cybersecurity solutions, including network intrusion detection and prevention systems.

INVO Fertility, Inc. is a specialized healthcare company focused on delivering accessible assisted reproductive technology solutions. It develops, manufactures and markets the patented INVOcell intravaginal culture system for in vitro fertilization procedures, serving fertility clinics and patients across North America, Europe and other global regions, with a mission to reduce barriers to high-quality fertility care.

INTZ vs IVF — Head-to-Head

Bigger by revenue
IVF
IVF
1.2× larger
IVF
$1.8M
$1.5M
INTZ
Growing faster (revenue YoY)
IVF
IVF
+34.2% gap
IVF
22.6%
-11.6%
INTZ
Higher net margin
IVF
IVF
40.2% more per $
IVF
-150.5%
-190.7%
INTZ
More free cash flow
INTZ
INTZ
$1.2M more FCF
INTZ
$-549.0K
$-1.8M
IVF
Faster 2-yr revenue CAGR
INTZ
INTZ
Annualised
INTZ
14.4%
12.8%
IVF

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
INTZ
INTZ
IVF
IVF
Revenue
$1.5M
$1.8M
Net Profit
$-2.8M
$-2.6M
Gross Margin
74.3%
Operating Margin
-192.4%
-93.1%
Net Margin
-190.7%
-150.5%
Revenue YoY
-11.6%
22.6%
Net Profit YoY
-44.4%
-62.2%
EPS (diluted)
$-0.15
$-0.77

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INTZ
INTZ
IVF
IVF
Q4 25
$1.5M
Q3 25
$2.0M
$1.8M
Q2 25
$1.9M
$1.9M
Q1 25
$1.8M
$1.6M
Q4 24
$1.7M
$1.7M
Q3 24
$1.5M
$1.4M
Q2 24
$1.5M
$1.8M
Q1 24
$1.1M
$1.6M
Net Profit
INTZ
INTZ
IVF
IVF
Q4 25
$-2.8M
Q3 25
$-2.1M
$-2.6M
Q2 25
$-2.0M
$-5.3M
Q1 25
$-2.1M
$-17.4M
Q4 24
$-2.0M
$-3.6M
Q3 24
$-2.0M
$-1.6M
Q2 24
$-2.1M
$-2.2M
Q1 24
$-1.7M
$-1.6M
Gross Margin
INTZ
INTZ
IVF
IVF
Q4 25
74.3%
Q3 25
76.6%
Q2 25
76.4%
Q1 25
75.7%
35.2%
Q4 24
74.9%
41.4%
Q3 24
77.1%
31.0%
Q2 24
76.0%
53.1%
Q1 24
80.0%
45.3%
Operating Margin
INTZ
INTZ
IVF
IVF
Q4 25
-192.4%
Q3 25
-108.6%
-93.1%
Q2 25
-111.4%
-160.4%
Q1 25
-117.9%
-1042.1%
Q4 24
-113.5%
-202.0%
Q3 24
-135.5%
-90.7%
Q2 24
-139.2%
-100.9%
Q1 24
-218.6%
-95.7%
Net Margin
INTZ
INTZ
IVF
IVF
Q4 25
-190.7%
Q3 25
-106.5%
-150.5%
Q2 25
-109.0%
-283.6%
Q1 25
-118.2%
-1060.1%
Q4 24
-116.8%
-211.3%
Q3 24
-136.3%
-113.8%
Q2 24
-141.6%
-122.2%
Q1 24
-151.7%
-101.3%
EPS (diluted)
INTZ
INTZ
IVF
IVF
Q4 25
$-0.15
Q3 25
$-0.10
$-0.77
Q2 25
$-0.10
$-13.30
Q1 25
$-0.11
$-12.53
Q4 24
$0.19
$14.86
Q3 24
$-0.35
$-15.11
Q2 24
$-0.53
$-22.39
Q1 24
$-0.94
$-7.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INTZ
INTZ
IVF
IVF
Cash + ST InvestmentsLiquidity on hand
$3.6M
Total DebtLower is stronger
$2.0M
Stockholders' EquityBook value
$7.3M
$5.8M
Total Assets
$10.4M
$18.8M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INTZ
INTZ
IVF
IVF
Q4 25
$3.6M
Q3 25
$4.5M
Q2 25
$8.4M
Q1 25
$10.7M
Q4 24
$4.9M
Q3 24
$1.1M
Q2 24
$1.5M
Q1 24
$122.0K
Total Debt
INTZ
INTZ
IVF
IVF
Q4 25
Q3 25
$2.0M
Q2 25
$4.8M
Q1 25
Q4 24
$7.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
INTZ
INTZ
IVF
IVF
Q4 25
$7.3M
Q3 25
$9.8M
$5.8M
Q2 25
$11.6M
$2.6M
Q1 25
$13.4M
$3.3M
Q4 24
$6.3M
$12.7M
Q3 24
$2.6M
$-23.3K
Q2 24
$2.9M
$1.4M
Q1 24
$-1.2M
$10.2K
Total Assets
INTZ
INTZ
IVF
IVF
Q4 25
$10.4M
Q3 25
$13.7M
$18.8M
Q2 25
$16.4M
$19.3M
Q1 25
$18.0M
$31.7M
Q4 24
$11.5M
$46.4M
Q3 24
$7.4M
$17.0M
Q2 24
$7.5M
$17.8M
Q1 24
$5.7M
$17.3M
Debt / Equity
INTZ
INTZ
IVF
IVF
Q4 25
Q3 25
0.34×
Q2 25
1.83×
Q1 25
Q4 24
0.59×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INTZ
INTZ
IVF
IVF
Operating Cash FlowLast quarter
$-531.0K
$-1.8M
Free Cash FlowOCF − Capex
$-549.0K
$-1.8M
FCF MarginFCF / Revenue
-37.1%
-101.6%
Capex IntensityCapex / Revenue
1.2%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.5M
$-7.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INTZ
INTZ
IVF
IVF
Q4 25
$-531.0K
Q3 25
$-3.0M
$-1.8M
Q2 25
$-1.6M
$-1.7M
Q1 25
$-1.7M
$-3.5M
Q4 24
$-178.0K
$-617.4K
Q3 24
$-2.1M
$-640.8K
Q2 24
$-2.9M
$-1.5M
Q1 24
$-1.1M
$-260.6K
Free Cash Flow
INTZ
INTZ
IVF
IVF
Q4 25
$-549.0K
Q3 25
$-3.0M
$-1.8M
Q2 25
$-1.9M
$-1.7M
Q1 25
$-2.1M
$-3.6M
Q4 24
$-645.0K
$-696.3K
Q3 24
$-2.1M
Q2 24
$-3.0M
$-1.5M
Q1 24
$-1.2M
$-310.3K
FCF Margin
INTZ
INTZ
IVF
IVF
Q4 25
-37.1%
Q3 25
-153.2%
-101.6%
Q2 25
-101.1%
-92.6%
Q1 25
-117.3%
-216.9%
Q4 24
-38.5%
-40.6%
Q3 24
-140.4%
Q2 24
-202.3%
-82.3%
Q1 24
-104.2%
-19.7%
Capex Intensity
INTZ
INTZ
IVF
IVF
Q4 25
1.2%
Q3 25
1.7%
0.5%
Q2 25
17.8%
0.5%
Q1 25
22.1%
0.9%
Q4 24
27.9%
4.6%
Q3 24
2.2%
0.0%
Q2 24
2.1%
3.0%
Q1 24
5.7%
3.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons